{'fraction_non_alphanumeric': 0.02027027027027027, 'fraction_numerical': 0.005287896592244419, 'mean_word_length': 5.573359073359073, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pain after surgery.

Pain after major surgery likely contributes to 30-day major morbidity and mortality, treatment of postoperative pain contributes to sustained opioid use and misuse, and for some, surgery leads to persistent pain.6 For these reasons, a better understanding of acute and chronic pain after surgery is needed. There are 3 main contributors to the severity and duration of postoperative pain. First, patients bring risk factors for more severe pain with them to surgery, the most important being preexisting pain, chronic opioid use, and the surgical procedure to be performed.1 Conversely, the peripartum period is associated with less severe and shorter lasting pain.7 It is important to recognize, however, that predictive models have rarely been replicated from 1 study to another, and that risk factors common to many models together only are only fair predictors of the presence of long-lasting pain. Second, surgery obligatorily injures peripheral tissues, resulting in pain with a pathophysiology distinct from that of pure infl ammation. As shown in preclinical rodent experiments, skin and muscle injury results in tissue hypoxemia and acidemia, release of infl ammatory mediators, nerve growth factor, reactive oxygen species, lactate, and other factors which result in spontaneous activity, lowered threshold, and enlarged receptive fi elds of nociceptors, especially nociceptors of the Aδ type.2,4,8,10,11 Additional nerve injury adds a large reduction in receptive fi eld area and increase in threshold in Aβ afferents, a further increase in receptive fi eld area in Aδ afferents, and a further reduction in threshold for nociceptors.3 Third, altered afferent input results in sensitization of the central nervous system processing and transmission of nociception, manifested as pain and areas of hypersensitivity to tactile stimuli. The mechanisms for this amplifi cation and sensitization are manifold but involve afferent release of glutamate (Glu), substance P (sP), calcitonin gene-related peptide, and products from the glia in the spinal cord.9 Local anesthetics administered alone or with opioids or α2-adrenoceptor agonists near the spinal cord inhibit pain transmission in this setting. Local infi ltration and perineural administration of local anesthetics and systemic nonsteroidal and steroidal antiinfl ammatory drugs treat acute postoperative pain primarily by peripheral mechanisms, whereas other systemic drugs such as opioids and ketamine or spinally administered drugs act primarily in the central nervous system. It is unclear whether antiepileptic and antidepressant drugs used to treat chronic pain reduce pain or opioid use after surgery, although the former are commonly used. Multimodal pharmacologic, interventional, and nonpharmacologic methods as part of an enhanced recovery after surgery comprehensive program can shorten time to hospital discharge and reduce opioid use while in hospital. Despite all these treatment options, many patients continue to experience severe pain in the days after surgery,5 most likely refl ecting both system failures and drug or treatment failures. And none of these treatments have been defi nitively demonstrated to either speed recovery from pain after hospital discharge, although multimodel treatment acutely after surgery can enhance analgesia, reduce side effects, and shorten time to hospital discharge.